These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917 [TBL] [Abstract][Full Text] [Related]
28. The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature. Fernandez B; Strootman D Angiology; 2006; 57(1):99-102. PubMed ID: 16444463 [TBL] [Abstract][Full Text] [Related]
29. [Thromboangitis obliterans in Korea. (Re-evaluation of Buerger's disease)]. LEE YK Taehan Uihak Hyophoe Chi; 1962 May; 5():266-73. PubMed ID: 14463592 [No Abstract] [Full Text] [Related]
30. A follow-up study of patient with thromboangiitis obliterans (Buerger's disease). CAMPBELL KN; HARRIS BM; COLLER FA Surgery; 1949 Dec; 26(6):1003-13. PubMed ID: 15395864 [No Abstract] [Full Text] [Related]
32. Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors. Abeles AM; Nicolescu M; Pinchover Z; Abeles M Vascular; 2014 Aug; 22(4):313-6. PubMed ID: 24000082 [TBL] [Abstract][Full Text] [Related]
33. Buerger's disease or Buerger's syndrome? An analysis of 12 cases. Scharf GM; van Wyk FA; Cloete GN; Rautenbach BK S Afr Med J; 1986 Dec; 70(13):803-5. PubMed ID: 3798265 [TBL] [Abstract][Full Text] [Related]
35. Atypical chronic sterile paronychia leading to tissue and joint space destruction in a patient with thromboangiitis obliterans. Yelkovan B; Thai KE Australas J Dermatol; 2014 Feb; 55(1):e9-e11. PubMed ID: 23127186 [TBL] [Abstract][Full Text] [Related]